Literature DB >> 22565566

Successful treatment of multiple basaliomas with bleomycin-based electrochemotherapy: a case series of three patients with Gorlin-Goltz syndrome.

Erika Kis1, Eszter Baltás, Agnes Kinyó, Erika Varga, Nikoletta Nagy, Rolland Gyulai, Lajos Kemény, Judit Oláh.   

Abstract

Gorlin-Goltz syndrome is a rare multisystemic disease, characterized by numerous basal cell carcinomas. The ideal approach for patients with the syndrome would be a treatment with a high cure rate, minimal scarring, short healing time and mild side-effects. Electrochemo-therapy is a novel therapeutic option that ablates tumours with electrical current and simultaneously administered anticancer drugs. Three patients with Gorlin-Goltz syndrome were treated with electrochemotherapy using intravenous bleomycin. Clinical response was obtained in 98 (99%) of the lesions, 86 (87%) of them showed complete response. In 2 tumours, regression was confirmed with histological examination. Long-term cosmetic results were excellent. We consider electrochemotherapy to be an additional tool in the therapeutic armamentarium for Gorlin-Goltz syndrome, and suggest using it as early as possible in selected patients to avoid disfiguring scarring.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565566     DOI: 10.2340/00015555-1361

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

Review 1.  [Alternative treatment options for periorbital basal cell carcinoma].

Authors:  Vinodh Kakkassery; Steffen Emmert; Irenäus A Adamietz; György Kovács; Anselm M Jünemann; Caroline Otte; Michael Zimbelmann; Anton Brosig; Salvatore Grisanti; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

2.  High-throughput, Label-Free Quantitative Proteomic Studies of the Anticancer Effects of Electrical Pulses with Turmeric Silver Nanoparticles: an in vitro Model Study.

Authors:  Lakshya Mittal; Ignacio G Camarillo; Gowri Sree Varadarajan; Hemalatha Srinivasan; Uma K Aryal; Raji Sundararajan
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

3.  Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008-2019).

Authors:  Giulia Bertino; Tobian Muir; Joy Odili; Ales Groselj; Roberto Marconato; Pietro Curatolo; Erika Kis; Camilla Kjaer Lonkvist; James Clover; Pietro Quaglino; Christian Kunte; Romina Spina; Veronica Seccia; Francesca de Terlizzi; Luca Giovanni Campana
Journal:  Curr Oncol       Date:  2022-07-28       Impact factor: 3.109

4.  Basal cell carcinoma: 10-year experience with electrochemotherapy.

Authors:  Luca G Campana; Roberto Marconato; Sara Valpione; Sara Galuppo; Mauro Alaibac; Carlo R Rossi; Simone Mocellin
Journal:  J Transl Med       Date:  2017-05-31       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.